Objectives To assess the frequency of major complications after multi-probe stereotactic
radiofrequency ablation (SRFA) in a large cohort of patients over 15 years and to elucidate …

Purpose To assess the technical outcome and local tumor control of multi-probe stereotactic
radiofrequency ablation (SRFA) in a large series of patients. Furthermore, to determine …

To assess the safety and clinical outcomes of multi-probe stereotactic radiofrequency
ablation (SRFA) for very large (≥ 8 cm) primary and metastatic liver tumors with curative …

Objective: The only curative treatment for primary and secondary hepatic malignancies is
surgery and liver transplantation. Thus, the majority of the patients are not candidates for …

Radiofrequency ablation (RFA) has become an important option in the therapy of primary
and secondary hepatic tumors. Surgical resection is still the best treatment option, but only a …

Purpose To evaluate technique effectiveness, safety, and interoperator performance of
stereotactic radiofrequency ablation (SRFA) of liver lesions. Methods Retrospective review …

Background: Radiofrequency ablation (RFA) has become a common treatment of patients
with unresectable primary and secondary hepatic malignancies. We performed this …

AIM: To investigate the major complications after radiofrequency ablation (RFA) for the
treatment of liver tumors and analyze possible risk factors that precipitate these …

Objective: This study aims to evaluate the effect of operator experience on the treatment
outcomes of radiofrequency ablation (RFA) for malignant liver tumors. Summary Background …

Many malignancies in the liver, whether primary or metastatic, are deemed unresectable
secondary to size, bilobar disease, or proximity to major vessels (Fig. 1). Recently, thermal …